Trials / Completed
CompletedNCT00569621
A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
It is known that several common eye diseases are associated with ocular perfusion abnormalities. Moxaverine is used in the therapy of perfusion abnormalities in the brain, the heart and the extremities because of its direct vasodilatory effects. The present study seeked to investigate whether moxaverine alters ocular blood flow in healthy volunteers after intravenous administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxaverine | intravenous administration |
| DRUG | physiological saline | intravenous administration |
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-07-01
- First posted
- 2007-12-07
- Last updated
- 2007-12-07
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00569621. Inclusion in this directory is not an endorsement.